4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline and Akinetic-Rigid Variant of Huntington Disease

4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hutson, PH; Pearson, SJ; Reynolds, GP	1

Other Studies

1 other study(ies) available for 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline and Akinetic-Rigid Variant of Huntington Disease

Article	Year
Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease. Journal of the neurological sciences, 1994, Volume: 125, Issue:1 Topics: Adult; Aged; Aminoquinolines; Binding Sites; Cadaver; Caudate Nucleus; Female; Frontal Lobe; Glycine; Humans; Huntington Disease; Male; Middle Aged; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tritium	1994

Article

Year

Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease.

Journal of the neurological sciences, 1994, Volume: 125, Issue:1

Topics: Adult; Aged; Aminoquinolines; Binding Sites; Cadaver; Caudate Nucleus; Female; Frontal Lobe; Glycine; Humans; Huntington Disease; Male; Middle Aged; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tritium

1994